Financings In the third quarter of 2011, biopharma start-ups raised $299 million – $48 million more than last quarter, with more than half of the funding going to Series A rounds. ( See Exhibit 1. )Me
In Vitro Diagnostics Mergers & Acquisitions Opko Health Inc. Claros Diagnostics Inc. Opko Health Inc. (drugs and diagnostics) has acquired privately held point-of-care testing company Claros Dia